Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
WSD0922 is an EGFR inhibitor with blood brain barrier penetration activity, which may lead to anti-tumor activity in EGFR mutant CNS tumor and brain metastasis (Proceedings of the American Association for Cancer Research, Vol 60, Mar 2019, Abstract #1326).
|DrugClasses||EGFR Inhibitor (Pan) 58|
|CAS Registry Number||NA|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|